Microsatellite instability in human cancer: A prognostic marker for chemotherapy?

Experimental Cell Research

Volumn 246, Issue 1, 1999, Pages 1-10

  Claij, Nanna ^a   Te Riele, Hein ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cancer; Chemotherapy; HNPCC; Microsatellite instability; Mismatch repair

Indexed keywords

6 O METHYLGUANINE; ANTINEOPLASTIC AGENT; BUSULFAN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; STREPTOZOCIN; TEMOZOLOMIDE; TIOGUANINE;

BASE MISPAIRING; COLORECTAL CANCER; DIAGNOSTIC VALUE; DNA DAMAGE; DNA REPLICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0033540281     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4299     Document Type: Review

References (137)

1. Hartwell L. Cell. 71:1992;543-546.
2. Strand M., Prolla T. A., Liskay R. M., Petes T. D. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature. 365:1993;274-276.
3. Loeb L. A. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res. 54:1994;5059-5063.
4. Ionov J., Peinado P. A., Malkhosyan S., Shibata D., Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 363:1993;558-561.
5. Aaltonen L. A., Peltomäki P., Leach F. S., Sistonen P., Pylkkanan L., Mecklin J. P., Jarvinen H., Powell S. M., Jen J., Hamilton S. R. Clues to the pathogenesis of familial colorectal cancer. Science. 260:1993;812-816.
6. Thibodeau S., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 260:1993;816-819.
7. Lynch H. T., Smyrk T. C., Watson P., Lanspa S. J., Lynch J. F., Cavalieri R. J., Bolland C. R. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review. Gastroenterology. 104:1993;1535-1549.
8. Lynch H. T., Smyrk T., Lynch J., Fitzgibbons R. Jr., Lanspa S., McGinn T. Update on the differential diagnosis, surveillance and management of hereditary non-polyposis colorectal cancer. Eur. J. Cancer. 31A:1995;1039-1046.
9. Cohen P. R., Kohn S. R., Kuzrock R. Association of sebaceous gland tumours and internal malignancy: The Muir-Torre syndrome. Am. J. Med. 90:1991;606-613.
10. Fishel R., Lescoe M. K., Rao M. R. S., Copeland N. G., Jenkins N. A., Garber J., Kane M., Kolodner R. The human mutator homologMSH2. Cell. 75:1993;1027-1038.
11. Leach F. S., Nicolaides N. C., Papadopoulos N., Liu B., Jen J., Parsons R., Peltomäki P., Sistonen P., Aaltonen L. A., Nystrom-Lahti M. Mutations of amutS. Cell. 75:1993;1215-1225.
12. +. Cell. 75:1993;1227-1236.
13. Bronner C. E., Baker S. M., Morrison P. T., Warren G., Smith L. G., Lescoe M. K., Kane M., Earabino C., Lipford J., Lindblom A. Mutation in the DNA mismatch repair gene homologuehMLH1. Nature. 368:1994;258-261.
14. Kolodner R. D., Hall N. R., Lipford J., Kane M. F., Rao M. R., Morrison P., Wirth L., Finan P. J., Burn J., Chapman P. Structure of the humanMSH2msh2. Genomics. 24:1994;516-526.
15. Kolodner R. D., Hall N. R., Lipford J., Kane M. F., Morrison P. T., Finan P. J., Burn J., Chapman P., Earabino C., Merchant E. Structure of the humanMLH1mlh1. Cancer Res. 55:1995;242-248.
16. Liu B., Parsons R. E., Hamilton S. R., Petersen G. M., Lynch H. T., Watson P., Markowitz S., Willson J. K., Green J., de la Chapelle A. hMSH2. Cancer Res. 54:1994;4590-4594.
17. Nicolaides N. C., Papadopoulos N., Liu B., Wei Y. F., Carter K. C., Ruben S. M., Rosen C. A., Haseltine W. A., Fleischman R. D., Fraser C. M. Mutations of twoPMS. Nature. 371:1994;75-80.
18. Papadopoulos N., Nicolaides N. C., Wei Y. F., Ruben S. M., Carter K. C., Rosen C. A., Haseltine W. A., Fleischman R. D., Fraser C. M., Adams M. D. Mutation of amutL. Science. 263:1994;1625-1629.
19. Akiyama Y, Sato H., Yamada T., Nagasaki H., Tsuchiya A., Abe R., Yuasa Y. Germ-line mutation of thehMSH6/GTBP. Cancer Res. 57:1997;3920-3923.
20. Miyaki M., Konishi M., Tanaka K., Kikuchi-Yanoshita R., Muraoka M., Yasuno M., Igari T., Koike M., Chiba M., Mori T. Germline mutation ofMSH6. Nature Genet. 17:1997;271-272.
21. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10:1996;1433-1442.
22. Hemminki A., Peltomaki P., Mecklin J.-P., Jarvinen H., Salovaara R., Nystrom-Lahti M., de la Chapelle A., Aaltonen L. A. Loss of the wild typeMLH1. Nature Genet. 8:1994;405-410.
23. Lu S.-L., Akiyama Y., Nagasaki H., Nomizu T., Ikeda E., Baba S., Ushio K., Iwama T., Maruyama K., Yuasa Y. Loss or somatic mutations ofhMSH2hMSH2. Jpn. J. Cancer Res. 87:1996;279-287.
24. Modrich P. Mechanisms and biological effects of mismatch repair. Annu. Rev. Genet. 25:1991;229-253.
25. Friedberg E. C., Walker G. C., Siede W. Mismatch repair. DNA Repair and Mutagenesis. 1995;ASM Press, Washington. p. 367-399.
26. Rayssiguier C., Thaler D. S., Radman M. The barrier to recombination betweenEscherichia coliSalmonella typhimurium. Nature. 342:1989;396-401.
27. Worth L. Jr., Clark S., Radman M., Modrich P. Mismatch repair proteins MutS and MutL inhibit RecA-catalyzed strand transfer between diverged DNAs. Proc. Natl. Acad. Sci. USA. 91:1994;3238-3241.
28. Marsischky G. T., Filosi N., Kane M. F., Kolodner R. Redundancy ofSaccharomyces cerevisiae MSH3MSH6MSH2. Genes Dev. 10:1996;407-420.
29. Drummond J. T., Li G.-M., Longley M. J., Modrich P. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science. 268:1995;1909-1912.
30. Palombo F., Gallinary P., Iaccarino I., Lettieri T., Hughes M., D'rrigo A., Truong O., Hsuan J. J., Jiricny J. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science. 268:1995;1912-1914.
31. Iaccarino I., Palombo F., Drummond J., Totty N. F., Hsuan J. J., Modrich P., Jiricny J. MSH6, aSaccharomyces cerevisiae. Curr. Biol. 6:1996;484-486.
32. Drummond J. T., Genschel J., Wolf E., Modrich P. DHFR/MSH3. Proc. Natl. Acad. Sci. USA. 94:1997;10144-10149.
33. Marra G., Iaccarino I., Lettieri T., Roscilli G., Delmastro P., Jiricny J. Mismatch repair deficiency associated with overexpression of theMSH3. Proc. Natl. Acad. Sci. USA. 95:1998;8568-8573.
34. Umar A., Risinger J. I., Glaab W. E., Tindall K. R., Barrett J. C., Kunkel T. A. Functional overlap in mismatch repair by humanMSH3MSH6. Genetics. 148:1998;1637-1646.
35. Genschel J., Littman S. J., Drummond J. T., Modrich P. Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutSα J. Biol. Chem. 273:1998;19895-19901.
36. Risinger J. I., Umar A., Boyd J., Berchuck A., Kunkel T. A., Barrett J. C. Mutation ofMSH3. Nature Genet. 14:1996;102-105.
37. Li G. M., Modrich P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc. Natl. Acad. Sci. USA. 92:1995;1950-1954.
38. De Wind N., Dekker M., Berns A., Radman M., Te Riele H. Inactivation of the mouseMsh2. Cell. 82:1995;321-330.
39. Malkhosyan S., Rampino N., Yamamoto H., Perucho M. Frameshift mutator mutations. Nature. 382:1996;499-450.
40. Karran P., Bignami M. DNA damage tolerance, mismatch repair and genome instability. BioEssays. 16:1994;833-839.
41. Karran P., Hampson R. Genomic instability and tolerance to alkylating agents. Cancer Surv. 28:1996;69-85.
42. Umar A., Koi M., Risinger J. I., Glaab W. E., Tindall K. R., Kolodner R. D., Boland C. R., Barrett J. C., Kunkel T. A. Correction of hypermutability,NNNMSH2MSH6. Cancer Res. 57:1997;3949-3955.
43. Koi M., Umar A., Chahan D. P., Cherian S. P., Carethers J. M., Kinkel T. A., Boland C. R. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reducesNNNhMLH1. Cancer Res. 54:1994;4308-4312.
44. Risinger J. I., Umar A., Barrett J. C., Kunkel T. A. AhPMS2. J. Biol. Chem. 270:1997;18183-18186.
45. Liu L., Markowitz S., Gerson S. L. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res. 56:1996;5375-5379.
46. 6. Proc. Natl. Acad. Sci. USA. 87:1990;5368-5372.
47. 4. Proc. Natl. Acad. Sci. USA. 93:1996;6443-6447.
48. Griffin S., Branch P., Xu Y.-Z., Karran P. DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage. Biochemistry. 33:1994;4787-4793.
49. Zamble D. B., Lippard S. J. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem. Sci. 20:1995;435-439.
50. Jones S. L., Hickson I. D., Harris A. L., Harnett P. R. Repair of cisplatin-DNA adducts by protein extracts from human ovarian carcinoma. Int. J. Cancer. 59:1994;388-393.
51. Zamble D. B., Mu D., Reardon J. T., Sancar A., Lippard S. J. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry. 35:1996;10004-10013.
52. Fram R. J., Cusick P. S., Wilson J. M., Marinus M. G. Mismatch repair ofcis. Mol. Pharmacol. 28:1985;51-55.
53. Anthoney D. A., McIlwrath A. J., Gallagher W. M., Edlin A. R. M., Brown R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res. 56:1996;1374-1381.
54. Drummond J. T., Anthoney A., Brown R., Modrich P. Cisplatin and adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumor cell line. J. Biol. Chem. 271:1996;19645-19648.
55. Aebi S., Kurdi-Haidar B., Gordon R., Cenni B., Zheng H., Fink D., Christen R. D., Boland C. R., Koi M., Fishel R., Howell S. B. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56:1996;3087-3090.
56. Fink D., Nebel S., Aebi S., Zheng H., Cenni B., Nehmé A., Christen R. D., Howell S. B. The role of DNA mismatch repair in platinum drug resistance. Cancer Res. 56:1996;4881-4886.
57. Mello J. A., Acharya S., Fishel R., Essigman J. M. The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3:1996;579-589.
58. Mu D., Tursun M., Duckett D. R., Drummond J. T., Modrich P., Sancar A. Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol. Cell. Biol. 17:1997;760-769.
59. Yamada M., O'egan E., Brown R., Karran P. Selective recognition of a cisplatin-DNA aduct by human mismatch repair proteins. Nucleic Acids Res. 25:1997;491-495.
60. Zhukovskaya N., Branch P., Aquilina G., Karran P. DNA replication arrest and tolerance to DNA mehylation damage. Carcinogenesis. 15:1994;2189-2194.
61. Hawn M. T., Umar A., Carethers J. M., Marra G., Kunkel T. A., Boland C. R., Koi M. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res. 55:1995;3721-3725.
62. Swann P. F., Waters T. R., Moulton D. C., Xu Y.-Z., Zheng Q., Edwards M., Mace R. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science. 273:1996;1109-1111.
63. Friedman H. S., Johnson S. P., Dong Q., Schold S. C., Rasheed B. K., Bigner S. H., Ali-Osman F., Dolan E., Colvin O. M., Houghton P., Germain G., Drummond J. T., Keir S., Marcelli S., Bigner D. D., Modrich P. Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res. 57:1997;2933-2936.
64. Aebi S., Fink D., Gordon R., Kim H. K., Fink J. L., Howell S. B. Resistance to cytotoxic drugs in DNA mismatch repair deficient cells. Clin. Cancer Res. 3:1997;1763-1767.
65. Fink D., Nebel S., Norris P. S., Aebi S., Kim H. K., Haas M., Howell S. B. The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair deficient tumour cells. Br. J. Cancer. 77:1998;703-708.
66. Fink D., Zheng H., Nebel S., Norris P. S., Aebi S., Lin T.-P., Nehmé A., Christen R. D., Haas M., Macleod C. L., Howell S. B. In vitroin vivo. Cancer Res. 57:1997;1841-1845.
67. Brown R., Hirst G. L., Gallagher W. M., McIlwrath A. J., Margison G. P., Van der Zee A. G. J., Anthoney D. A. hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents. Oncogene. 15:1997;45-52.
68. Ben-Yehuda D., Krichevski S., Caspi O., Rund D., Polliack A., Abeliovich D., Zelig O., Yahalom V., Paltiel O., Or R., Peretz T., Ben-Neriah S., Yehuda O., Rachmilewitz E. A. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood. 88:1996;4296-4303.
69. Yamamoto H., Sawai H., Weber T. K., Rodriguez-Bigas M. A., Perucho M. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res. 58:1998;997-1003.
70. Field J. K., Kiaris H., Howard P., Vaughan E. D., Spandidos D. A., Jones A. S. Microsatellite instability in squamous cell carcinoma of the head and neck. Br. J. Cancer. 71:1995;1065-1069.
71. El-Naggar A. K., Hurr K., Huff V., Clayman G. L., Luna M. A., Batsakis J. G. Microsatellite instability in preinvasive and invasive head and neck squamous carcinoma. Am. J. Pathol. 148:1996;2067-2072.
72. Soares P., dos Santos N. R., Seruca R., Lothe R. A., Sobrinho-Simões M. Benign and malignant thyroid lesions show instability at microsatellite loci. Eur. J. Cancer. 33:1997;293-296.
73. Muzeau F., Fléjou J-F., Belghiti J., Thomas G., Hamelin R. Infrequent microsatellite instability in oesophageal cancers. Br. J. Cancer. 75:1997;1336-1339.
74. Nakashima H., Mori M., Mimori K., Inoue H., Shibuta K., Baba K., Mafune K., Akiyoshi T. Microsatellite instability in Japanese esophageal carcinoma. Int. J. Cancer. 64:1995;286-289.
75. Meltzer S. J., Yin J., Manin B., Rhyu M-G., Cottrell J., Hudson E., Redd J. L., Krasna M. J., Abraham J. M., Reid B. J. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett'-associated esophageal adenocarcinomas. Cancer Res. 54:1994;3379-3382.
76. Gleeson C. M., Sloan J. M., McGuigan J. A., Ritchie A. J., Weber J. L., Russell S. E. H. Widespread microsatellite instability occurs infrequently in adenocarcinoma of the gastric cardia. Oncogene. 12:1996;1653-1662.
77. Mironov N. M., Aguelon M. A-M., Potapova G. I., Omori Y., Gorbunov O. V., Klimenkov A. A., Yamasaki H. Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer. Cancer Res. 54:1994;41-44.
78. Nakashima H., Inoue H., Mori M., Ueo H., Ikeda M., Akiyoshi T. Microsatellite instability in Japanese gastric cancer. Cancer. 75:1995;1503-1507.
79. Lothe R. A., Peltomäki P., Meling G. I., Aaltonen L. A., Nyström-Lahti M., Pylkkänen L., Heimdal K., Andersen T. I., Moller P., Rognum T. O., Fosså S. D., Haldorsen T., Langmark F., Brogger A., de la Chapelle A., Borresen A-L. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res. 53:1993;5853-5855.
80. Seruca R., Santos N. R., David L., Constancia M., Barroca H., Carneiro F., Seixas M., Peltomäki P., Lothe R., Sobrinho-Simões M. Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile. Int. J. Cancer. 64:1995;32-36.
81. Chung Y. J., Song J. M., Lee J. Y., Jung Y. T., Seo E. J., Choi S. W., Rhyu M. G. Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population. Cancer Res. 56:1996;4662-4665.
82. Chung Y. J., Park S. W., Song J. M., Lee K. Y., Seo E. J., Choi S. W., Rhyu M. G. Evidence of genetic progression in human gastric carcinomas with microsatellite instability. Oncogene. 15:1997;1719-1726.
83. Rhyu M-G., Park W-S., Meltzer S. J. Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene. 9:1994;29-32.
84. Senba S., Konishi F., Okamoto T., Kasiwagi H., Kanazawa K., Miyaki M., Konishi M., Tsjukamoto T. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors. Cancer. 82:1998;279-285.
85. Ishimaru G., Adachi J., Shiseki M., Yamaguchi N., Muto T., Yokota J. Microsatellite instability in primary and metastatic colorectal cancers. Int. J. Cancer. 64:1995;153-157.
86. Lothe R. A., Peltomäki P., Meling G. I., Aaltonen L. A., Nyström-Lahti M., Pylkkänen L., Heimdal K., Andersen T. I., Moller P., Rognum T. O., Fosså S. D., Haldorsen T., Langmark F., Brogger A., de la Chapelle A., Borresen A-L. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res. 53:1993;5849-5852.
87. Cawkwell L., Li D., Lewis F. A., Martin I., Dixon M. F., Quirke P. Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology. 109:1995;465-471.
88. Kim H., Jen J., Vogelstein B., Hamilton S. R. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am. J. Pathol. 145:1994;148-156.
89. Koike J., Yamada K., Takano S., Kikuchi Y., Hemmi H., Koi M., Tsujita K., Yanagita K., Yoshio T., Shimatake H. Undetectable expression ofhMLH1. Dis. Colon Rectum. 40:1997;S23-S28.
90. Samowitz W. S., Slattery M. L., Kerber R. A. Microsatellite instability in human colonic cancer is not a useful clinical indicator of familial colorectal cancer. Gastroenterology. 109:1995;1765-1771.
91. Watanabe M., Imai H., Kato H., Shiraishi T., Ushijima T., Nagao M., Yatani R. Microsatellite instability in latent prostate cancers. Int. J. Cancer. 69:1996;394-397.
92. Watanabe M., Imai H., Shiraishi T., Shimazaki J., Kotake T., Yatani R. Microsatellite instability in human prostate cancer. Br. J. Cancer. 72:1995;562-564.
93. Dahiya R., Lee C., McCarville J., Hu W., Kaur G., Deng G. High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma. Int. J. Cancer. 72:1997;762-767.
94. Egawa S., Uchida T., Suyama K., Wang C., Ohori M., Irie S., Iwamura M., Koshiba K. Genomic instability of microsatellite repeats in prostate cancer: Relationship to clinicopathological variables. Cancer Res. 55:1995;2418-2421.
95. Uchida T., Wada C., Wang C., Ishida H., Egawa S., Yokoyama E., Othani H., Koshiba K. Microsatellite instability in prostate cancer. Oncogene. 10:1995;1019-1022.
96. Lothe R. A., Peltomäki P., Tommerup N., Fosså S. D., Stenwig A. E., Borresen A-L., Nesland J. M. Molecular genetic changes in human male germ cell tumors. Lab. Invest. 73:1995;606-614.
97. Wooster R., Cleton-Jansen A.-M., Collins N., Mangion J., Cornelis R. S., Cooper C. S., Gusterson B. A., Ponder B. A. JB. A., von Diemling A., Wiestler O. D., Cornelisse C. J., Devilee P., Stratton M. R. Instability of short tandem repeats (microsatellites) in human cancers. Nature Genet. 6:1994;152-156.
98. Tangir J., Loughridge N. S., Berkowitz R. S., Muto M. G., Bell D. A., Welch W. R., Mok S. C. Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res. 56:1996;2501-2505.
99. Kobayashi K., Sagae S., Kudo R., Saito H., Koi S., Nakamura Y. Microsatellite instability in endometrial carcinomas: Frequent replication errors in tumors of early onset and/or of poorly differentiated type. Genes Chrom. Cancer. 14:1995;128-132.
100. Risinger J. I., Umar A., Boyer J. C., Evans A. C., Berchuck A., Kunkel T. A., Barrett J. C. Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. Cancer Res. 55:1995;5664-5669.
101. Caduff R. F., Johnston C. M., Svoboda-Newman S. M., Poy E. L., Merajver S. D., Frank T. S. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Am. J. Pathol. 148:1996;1671-1678.
102. Katabuchi H., van Rees B., Lambers A. R., Ronnett B. M., Blazes M. S., Leach F. S., Cho K. R., Hedrick L. Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res. 55:1995;5556-5560.
103. Helland Å., Borresen-Dale A-L., Peltomäki P., Hektoen M., Kristensen G. B., Nesland J. M., de la Chapelle A., Lothe R. A. Microsatellite instability in cervical and endometrial carcinomas. Int. J. Cancer. 70:1997;499-501.
104. Lim P. C., Cliby W. A., Tester D., Thibodeau S., Podratz K. C., Jenkins R. B. Mutational analysis of DNA mismatch repair genes,MSH2MLH1. Gynecol. Oncol. 60:1996;106.
105. Larson A. A., Kern S., Sommers R. L., Yokota J., Cavenee W. K., Hampton G. M. Analysis of replication error (RER+) phenotypes in cervical carcinoma. Cancer Res. 56:1996;1426-1431.
106. Paulson T. G., Wright F. A., Parker B. A., Russack V., Wahl G. M. Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. Cancer Res. 56:1996;4021-4026.
107. Shaw J. A., Walsh T., Chappell S. A., Carey N., Johnson K., Walker R. A. Microsatellite instability in early sporadic breast cancer. Br. J. Cancer. 73:1996;1393-1397.
108. Yee C. J., Roodi N., Verrier C. S., Parl F. F. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res. 54:1994;1641-1644.
109. Zhu J., Guo S-Z., Beggs A. H., Maruyama T., Santarius T., Dasher K., Olsen N., Wu J. K., Black P. Microsatellite instability of primary human brain tumors. Oncogene. 12:1996;1417-1423.
110. Simon M., Kokkino A. J., Warnick R. E., Tew J. M., von Diemling A., Menon A. G. Role of genomic instability in meningioma progression. Genes ChromosomesCancer. 16:1996;265-269.
111. Quinn A. G., Healy E., Rehman I., Sikkink S., Rees J. L. Microsatellite instability in human non-melanoma and melanoma skin cancer. J. Invest. Dermatol. 104:1995;309-312.
112. Peris K., Keller G., Chimentie S., Amantea A., Kerl H., Höfler H. Microsatellite instability and loss of heterozygosity in melanoma. J. Invest . Dermatol. 105:1995;625-628.
113. Walker G. J., Palmer J. M., Walters M. K., Nancarrow D. J., Hayward N. K. Microsatellite instability in melanoma. Melanoma Res. 4:1994;267-268.
114. Richetta A., Silipo V., Calvieri S., Frati L., Ottini L., Cama A., Mariani-Constantini R. Microsatellite instability in primary and metastatic melanoma. J. Invest. Dermatol. 109:1997;119-120.
115. Tomlinson I. P. M., Beck N. E., Bodmer W. F. Allele loss on chromosome 11q and microsatellite instability in malignant melanoma. Eur. J. Cancer. 32A:1996;1797-1802.
116. Merlo A., Mabry M., Gabrielson E., Volmer R., Baylin S. B., Sidransky D. Frequent microsatellite instability in primary small cell lung cancer. Cancer Res. 54:1994;2098-2101.
117. Suzuki K., Ogura T., Yokose T., Sekine I., Nagai K., Kodama T., Mukai K., Nishiwaki Y., Esumi H. Microsatellite instability in female non-small-cell lung cancer patients with familial clustering of malignancy. Br. J Cancer. 77:1998;1003-1008.
118. Shridhar V., Siegfried J., Hunt J., del Mar Alonso M., Smith D. I. Genetic instability of microsatellite sequences in many non-small cell lung carcinomas. Cancer Res. 54:1994;2084-2087.
119. Gamberi B., Gaidano G., Parsa N., Carbone A., Roncella S., Knowles D. M., Louie D. C., Shibata D., Chaganti R. S. K., Dalla-Favera R. Microsatellite instability is rare in B-cell non-Hodgkin' lymphomas. Blood. 89:1997;975-979.
120. Tasaka T., Lee S., Spira S., Takeuchi S., Nagai M., Takahara J., Koeffler H. P. Microsatellite instability during progression of acute myelocytic leukaemia. Br. J. Haematol. 98:1997;219-221.
121. Sill H., Goldman J. M., Cross N. C. P. Rarity of microsatellite alterations in acute myeloid leukaemia. Br. J. Cancer. 74:1996;255-257.
122. Mori N., Takeuchi S., Tasaka T., Lee S., Spira S., Ben-Yehuda D., Mizoguchi H., Schiller G., Koeffler H. P. Absence of microsatellite instability during the progression of chronic myelocytic leukemia. Leukemia. 11:1997;151-152.
123. Wada C., Shionoya S., Fujino Y., Tokuhiro H., Akahoshi T., Uchida T., Ohtani H. Genomic instability of microsatellite repeats and its association with the evolution of chronic myelogenous leukemia. Blood. 12:1994;3449-3456.
124. Randerson J., Cawkwell L., Jack A., Child J. A., Lewis F., Hall N., Johnson P., Evans P., Barrans S., Morgan G. J. Microsatellite instability in follicle centre cell lymphoma. Br. J. Haematol . 93:1996;160-162.
125. Jacoby R. F., Marshall D. J., Kailas S., Schlack S., Harms B., Love R. Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gasteroenterology. 109:1995;73-82.
126. Dietmaier W., Wallinger S., Bocker T., Kullmann F., Fishel R., Rüschoff J. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res. 57:1997;4749-4756.
127. Borresen A-L., Lothe R. A., Meling G. I., Lystad S., Morrison P., Lipford J., Kane M. F., Rognum T. O., Kolodner R. D. Somatic mutations in thehMSH2. Hum. Mol. Genet. 4:1995;2065-2072.
128. Bubb V. J., Curtis L. J., Cunningham C., Dunlop M. G., Carothers A. D., Morris R. G., White S., Bird C. C., Wyllie A. H. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene. 12:1996;2641-2649.
129. Herfarth K. K.-F., Kodner I. J., Whelan A. J., Ivanovich J. L., Bracamontes J. R., Wells S. A., Goodfellow P. J. Jr. Mutations inMLH1MSH2. Genes Chromosomes Cancer. 18:1997;42-49.
130. Wu Y., Nyström-Lathi M., Osinga J., Looman M. W. G., Peltomäki P., Aaltonen L. A., de la Chapelle A., Hofstra R. M. W., Buys C. H. C. M. MSH2MLH1. Genes Chromosomes Cancer. 18:1997;269-278.
131. Konishi M., Kikuchi-Yanoshita R., Tanaka K., Muraoka M., Onda A., Okumura Y., Kishi N., Iwama T., Mori T., Koike M., Ushio K., Chiba M., Nomizu S., Konishi F., Utsunomiya J., Miyaki M. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology. 111:1996;307-317.
132. Liu B., Nicolaides N. C., Markowitz S., Willson J. K. V., Parsons R. E., Jen J., Papadopolous N., Peltomäki P., de la Chapelle A., Hamilton S. R., Kinzler K. W., Vogelstein B. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet. 9:1995;48-55.
133. Thibodeau S. N., French A. J., Roche P. C., Cunningham J. M., Tester D. J., Lindor N. M., Moslein G., Baker S. M., Liskay R. M., Burgart L. J., Honchel R., Halling K. C. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res. 56:1996;4836-4840.
134. Kane M. F., Loda M., Gaida G. M., Lipman J., Mishra R., Goldman H., Jessup J. M., Kolodner R. Methylation of thehMLH1. Cancer Res. 57:1997;808-811.
135. DaCosta L. T., Liu B., El-Deiry W. S., Hamilton S. R., Kinzler K. W., Vogelstein B., Makowitz S., Willson J. K. V., de la Chapelle A., Downey K. M., So A. G. Polymerase δ variants in RER colorectal tumours. Nature Genet. 9:1995;10-11.
136. Humbert O, Prudhomme M., Hakenbeck R., Dowson C. G., Claverys J.-P. Homeologous recombination and mismatch repair during transformation inStreptococcus pneumoniae: Proc. Natl. Acad. Sci. USA. 92:1995;9052-9056.
137. Schaaper R. M., Radman M. The extreme mutator effect ofEscherichia coli mutD5. EMBO J. 8:1989;3511-3516.